《新股消息》亞東集團(01795.HK)下限定價0.84元 一手中籤率25%
紡織面料供應商亞東集團(01795.HK)公布招股結果,發售價定於0.84元,為下限定價(招股價介乎0.84至1.08元),公開發售錄超購17.3倍,而因國際配售略微認購不足,經重新分配後,公開發售股數增至佔總數20%。每手3,000股,中籤率為25%。該股將於明日(11月18日)上市。富強金融資本為獨家保薦人。
公司預計集資淨額為8,190萬元,當中約63.1%將用於升級及改進集團現有的生產線及技術能力,擴大產能及產品範圍;約26.9%將用於收購一間於中國江蘇省擁有現有生產廠房的公司;及10%將用作一般企業用途及營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.